Post-Transplant HLA class II Antibodies and High Soluble CD30 Levels are Independently Associated with Poor Kidney Graft Survival
Open Access
- 1 April 2007
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (4) , 847-856
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- HLA Antibody Identification With Single Antigen Beads Compared To Conventional MethodsHuman Immunology, 2005
- High Pre‐Transplant Soluble CD30 Levels are Predictive of the Grade of RejectionAmerican Journal of Transplantation, 2005
- Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejectionTransplant Immunology, 2005
- CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 responseTransplant Immunology, 2003
- Accurate, rapid charaterization of HLA-specific antibody using luminex technologyHuman Immunology, 2003
- Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy1Transplantation, 2003
- Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome1Transplantation, 2003
- All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodiesTransplantation, 2002
- Monitoring of anti‐HLA class I and II antibodies by flow cytometry in patients after first cadaveric kidney transplantationClinical Transplantation, 2000
- Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cellsNature, 1982